Home Browse Products
Independent imaging intelligence

What will that equipment actually earn you?

Independent, study-verified benchmarks and facility-calibrated financial projections for hospitals, imaging centers, and radiology groups. Built on evidence, not the vendor's ROI deck.

Independent by design
No vendor funding
No sponsored placement
No GPO referral fees
Methodology disclosed
Market problem

Why imaging technology decisions are hard to underwrite.

Medical imaging purchases are financially material and operationally sensitive. A scanner, AI platform, PACS/RIS module, workflow tool, or imaging software contract can affect throughput, staffing, reimbursement, denial rates, radiologist productivity, patient access, integration burden, and long-term capital planning.

01
ROI claims may overstate value.
A faster scan, shorter read time, or workflow improvement only creates financial value when demand, staffing, scheduling, reimbursement, and downstream capacity allow the facility to capture the gain.
02
Pricing is opaque.
Comparable buyers may pay different amounts for product configuration, implementation, annual support, integrations, service terms, add-ons, and enterprise licenses.
03
Performance is difficult to compare.
Products differ across real-world workflow fit, PACS/RIS/EHR compatibility, implementation burden, training needs, and site-specific value capture.
04
Evidence is fragmented.
Useful signals sit across clinical studies, regulatory materials, vendor documents, case studies, reimbursement data, buyer conversations, and public market sources.

Intelligence layers built around the buying decision.

The platform is structured to move from product claim to evidence-weighted, buyer-specific, procurement-ready economic view.

01
Evidence-weighted KPI benchmarks
Scan-time reduction, read-time impact, workflow efficiency, repeat-rate reduction, denial-rate impact, throughput potential, staffing impact, and implementation burden are normalized and weighted by evidence quality.
02
Facility-specific financial modeling
Operational gains are translated into downside, base-case, and upside scenarios only when a real monetization path exists.
03
Pricing and contract intelligence
Expected price ranges, pricing structures, hidden fees, implementation costs, support fees, integration costs, module bundling, and negotiation questions are organized into a procurement-ready view.
04
Integration and workflow risk scoring
PACS, RIS, EHR, modality infrastructure, reporting workflow, cybersecurity requirements, IT burden, training, implementation timeline, and disruption risk are evaluated before value is assumed.
05
Buyer-specific fit assessment
A hospital radiology department, outpatient imaging center, radiology group, and PE-backed platform do not evaluate value the same way. Facility context changes the answer.
06
Procurement-ready decision support
Outputs include product profiles, opportunity estimates, benchmark summaries, diligence checklists, pricing questions, vendor comparison tables, and finance-committee-ready summaries.
How the model works

From product claim to decision-grade economic view.

Imaging Benchmark does not treat time savings as money by default. Every estimate is routed through baseline, constraint, evidence, monetization, and realization logic.

01
Select the product or category.
Start with a scanner, AI platform, PACS/RIS module, workflow tool, or imaging software category.
02
Enter facility context.
Add volume, modality mix, payer mix, staffing constraints, utilization, backlog, technology stack, and strategic goals.
03
Apply evidence and constraint logic.
KPI evidence grades, pricing provenance, integration risk, and monetization gates determine whether operational gains can become financial value.
04
Export a decision-ready view.
Use the output for vendor meetings, procurement review, capital committee, board discussion, or internal operating meetings.
Model discipline

What we will not assume.

×
No automatic monetization of time savings.
Time saved only matters financially when there is a capture mechanism.
×
No unweighted vendor claims.
A multi-site study, vendor case study, regulatory document, and buyer comment do not carry the same weight.
×
No ignored site-readiness costs.
DICOM conformance, middleware, interface builds, cybersecurity, training, and disruption costs stay in the model.
×
No paid influence on scoring.
Vendor participation, if allowed, must be labeled and cannot influence benchmarks, scoring, modeling, or editorial judgment.

CT Scanner Comparison

Data Sources, Methodology & Evidence Governance. Performance specifications sourced from manufacturer-published datasheets and FDA 510(k) summaries. Pricing ranges reflect list prices and peer-reported transaction data where available; actual negotiated prices vary by region, volume, and contract terms. Financial impact estimates are implementation-adjusted illustrative ranges derived from comparable-facility medians and user-supplied operating data. These are not guarantees of financial outcomes. Realization haircuts applied where operational dependencies are identified. Integration assessments based on vendor documentation and structured deployment reports. All claims carry evidence classification metadata. Data subject to change. See Methodology & Evidence Standards v2.1 for full disclosure.
Next step

Evaluate the economics before the vendor meeting.

Use Imaging Benchmark to pressure-test product claims, pricing assumptions, integration risk, and financial upside before committing capital or signing a contract.